DIFFUSE LARGE B-CELL LYMPHOMA

This adverse event was reported 7713 times

These drugs are most commonly taken by patients reporting DIFFUSE LARGE B-CELL LYMPHOMA:

# Drug Count
0 RITUXIMAB 2001
1 CYCLOPHOSPHAMIDE 1717
2 CYCLOPHOSPHAMIDE FOR INJECTION 1717
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 1717
4 PREDNISONE 1517
5 METHOTREXATE SODIUM 1377
6 DOXORUBICIN 1248
7 METHOTREXATE 1079
8 LENALIDOMIDE 960
9 PREDNISOLONE 939
See all common drugs associated with DIFFUSE LARGE B-CELL LYMPHOMA

DIFFUSE LARGE B-CELL LYMPHOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EPCORITAMAB-BYSP 251 0.1876
1 TAFASITAMAB-CXIX 42 0.0464
2 POLATUZUMAB VEDOTIN 428 0.0420
3 AXICABTAGENE CILOLEUCEL 403 0.0397
4 BENDAMUSTINE HCL 421 0.0269
5 ETOPOSIDE PHOSPHATE 41 0.0251
6 MOSUNETUZUMAB 23 0.0208
7 BENDAMUSTINE HYDROCHLORIDE 174 0.0204
8 GLOFITAMAB 48 0.0177
9 IFOSFAMIDE FOR INJECTION 325 0.0151
See all drugs enriched for association with DIFFUSE LARGE B-CELL LYMPHOMA